Inscrição YC de SFA Therapeutics

Summer 2021Active

SFA Therapeutics passou pela Y Combinator no batch Summer 2021 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.

Batch YC: Summer 2021
Indústria: HealthcareTherapeutics
Tamanho da equipe: 4
Status: Active
Lançada: 2021

Fundadores

Ira SpectorFounder
Alla ArzumanyanFounder
Mark FeitelsonFounder

O que SFA Therapeutics faz

SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.

Inscrição YC de SFA Therapeutics, reconstruída

Inscrição Y Combinator

SFA Therapeutics, lote Summer 2021. As verdadeiras perguntas do formulário, respondidas com dados públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

SFA Therapeutics

Describe what your company does in 50 characters or less.

Regulating the immune system to block cancer & autoimmune diseases

What is your company going to make? Please describe your product and what it does or will do.

We are developing orally-administered immunoregulators targeting chronic inflammation that drives autoimmune diseases and certain cancers. Our drugs block key immune pathways causing diseases like psoriasis, pancreatic cancer, uveitis, and NASH. We already have strong phase 1b clinical data for psoriasis and a pipeline of 9 drug candidates with 15 patents.

Where do you live now, and where would the company be based after YC?

We live and are based in Philadelphia, PA, USA. After YC, we plan to stay in Philadelphia to leverage local biotech resources and keep our team intact.

Explain your decision regarding location.

Philadelphia is where our founders are based and where we've built our scientific and clinical collaborations. It has a strong biotech community and is well suited for therapeutic development, so relocating after YC is unnecessary.

21 respostas a mais na inscrição completa

Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.

Ver inscrição completa

Perguntas Frequentes

Esta é a inscrição real da YC de SFA Therapeutics?

Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de SFA Therapeutics (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como SFA Therapeutics se apresentaria à YC, não o texto que eles submeteram.

Em qual batch da YC SFA Therapeutics esteve?

SFA Therapeutics fez parte do batch Summer 2021 da Y Combinator.

Quem fundou o SFA Therapeutics?

O SFA Therapeutics foi fundado por Ira Spector, Alla Arzumanyan, Mark Feitelson.

O que o SFA Therapeutics faz?

Regulating the immune system to block cancer & autoimmune diseases

Como eu leio o application completo reconstruído?

Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do SFA Therapeutics, e de todos os outros lotes do YC, está no YC Insights.